The response of dicumarol-induced hypoprothrombinemia to vitamin K.
作者信息
REHBEIN A, JARETZKI A, HABIF D V
出版信息
Ann Surg. 1952 Apr;135(4):454-69. doi: 10.1097/00000658-195204000-00003.
Abstract
摘要
相似文献
1
The response of dicumarol-induced hypoprothrombinemia to vitamin K.
Ann Surg. 1952 Apr;135(4):454-69. doi: 10.1097/00000658-195204000-00003.
2
3
Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.
Br Med J. 1952 Feb 23;1(4755):412-5. doi: 10.1136/bmj.1.4755.412.
4
Hypoprothrombinemia in biliary fistula dogs induced by minute doses of dicumarol.
Am J Physiol. 1952 Feb;168(2):287-91. doi: 10.1152/ajplegacy.1952.168.2.287.
5
Vitamin K1 in treatment of bishydroxycoumarin-induced hypoprothrombinemia; comparison of intravenous and intramuscular administration.
J Am Med Assoc. 1956 Jul 21;161(12):1145-7. doi: 10.1001/jama.1956.02970120027008.
6
The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia.
N Engl J Med. 1950 Nov 16;243(20):775-9. doi: 10.1056/NEJM195011162432004.
7
[Effects of vitamine K 1 on hypoprothrombinemia caused by dicumarol and on the acceleration factors in the rabbit with liver damage and the hepatectomized cat].
Acta Haematol. 1952 Mar;7(3):143-56. doi: 10.1159/000204047.
8
Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia.
J Am Med Assoc. 1951 Feb 10;145(6):393-9. doi: 10.1001/jama.1951.02920240029008.
9
Dihydrovitamin Kl biphosphate in bishydroxycoumarin induced hypoprothrombinemia.
J Lab Clin Med. 1960 Jul;56:21-4.
10
Intravenous emulsified vitamin K in the treatment of coumarin-induced hypoprothrombinemia.
Am Heart J. 1952 Jul;44(1):124-30. doi: 10.1016/0002-8703(52)90180-4.
引用本文的文献
1
Vitamin K1 in the control of phenylindanedione-induced anticoagulant therapy.
Can Med Assoc J. 1955 Feb 1;72(3):184-5.
2
The current status of the treatment of coronary heart disease.
Can Med Assoc J. 1953 Feb;68(2):95-103.
本文引用的文献
1
THE SYNTHESIS OF VITAMIN K1.
Science. 1940 Jan 12;91(2350):31-6. doi: 10.1126/science.91.2350.31.
2
Preliminary report on the clinical use of a new anticoagulant, phenylindandione.
Circulation. 1950 May;1(5):1195-1204. doi: 10.1161/01.cir.1.5.1195.
3
A new prothrombopenic drug, phenylindanedione.
Can Med Assoc J. 1950 May;62(5):465-70.
4
Major bleeding resulting from a single dose of dicumarol.
Ann Intern Med. 1950 Apr;32(4):731-5. doi: 10.7326/0003-4819-32-4-731.
5
Antagonism of dicumarol by vitamin K preparations.
N Engl J Med. 1950 Feb 9;242(6):211-5. doi: 10.1056/NEJM195002092420604.
6
The effects of 4 hydroxycoumarin anticoagulant No. 63 upon the prothrombin time in dogs and human beings.
J Lab Clin Med. 1950 Jan;35(1):8-15.
7
Clinical tests of a new coumarin substance; a report to the Medical Research Council.
Br Med J. 1949 Dec 3;2(4639):1250-4. doi: 10.1136/bmj.2.4639.1250.
8
The treatment of dicumarol-induced hypoprothrombinemia in man with emulsified vitamin K1 administered intravenously.
J Lab Clin Med. 1951 Feb;37(2):269-71.
9
Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties.
Circulation. 1951 Feb;3(2):164-70. doi: 10.1161/01.cir.3.2.164.
10
Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia.
J Am Med Assoc. 1951 Feb 10;145(6):393-9. doi: 10.1001/jama.1951.02920240029008.
Zotero 插件